The family of a 63-year-old man, who died in March in Haute-Savoie (central-eastern France) of “multiple thromboses” after receiving a first injection of AstraZeneca’s anti-COVID vaccine, has filed a complaint against X for “manslaughter”, we learned Tuesday from the prosecutor’s office in Annecy.
• Read also: [EN DIRECT 6 AVRIL] All the developments of the pandemic
• Read also: EMA official confirms link between AstraZeneca and thrombosis
“The complaint was lodged with me urgently this Tuesday morning”, confirmed to AFP Véronique Denizot, the public prosecutor of Annecy.
This is not the first procedure targeting the vaccine from the Anglo-Swedish laboratory in France: a complaint against X was filed in Toulouse (southwest) after the death of a 38-year-old woman and the Nantes prosecutor’s office. opened a preliminary investigation into the death of a medical student.
These complaints could be examined jointly by the Paris prosecutor’s office as part of a grouping. Otherwise, Ms. Denizot left the door open to “referral to an examining magistrate”.
According to the regional daily Le Dauphiné Libéré, which revealed the information, the complaint was registered by the gendarmes of Seynod on Friday April 2, a little more than two weeks after the death, on March 18 in Annecy, of this sixty-year-old who came to receive the first injection of the controversial COVID vaccine.
His relatives reported the tragedy to the National Medicines Safety Agency (ANSM), which ordered additional information to clarify the causes of his death.
Persuaded “at 95%” that a link with the vaccination can be established, the relatives of the victim try to have his death recognized as a consequence of the injection and to include it in the report on the adverse effects of AstraZeneca.
“In the space of a day and a half, he multiplied problems after problems, thromboses on vital organs, the liver, the kidneys, the brain… then he was placed in intensive care. It was dazzling, ”testifies his brother in a video published by the daily on its website.
On Tuesday, Rogerio Pinto de Sa Gaspar, the director of the World Health Organization (WHO), estimated that the risk / benefit balance continued to weigh “largely” in favor of the use of AstraZeneca’s anti-COVID vaccine .
The European Medicines Agency (EMA) said it was still assessing the safety of the vaccine in light of this new information.